Modern opportunities of therapeutic treatment of allergic conjunctivitis. A review
https://doi.org/10.18008/1816-5095-2014-2-19-26
Abstract
H1‑receptor antagonists are drugs of choice to treat allergy. They work very fast as their therapeutic effect develops within 10‑15 min, have good tolerability and almost no adverse side-effects, and require no frequent instillations. Levocabastine quickly inhibits allergic reaction caused by specific allergen or histamine. Levocabastine while being a highly-selective H1‑receptor antagonist is the most perspective topical mono-drug used to treat acute allergic conjunctivitis. Levocabastine applied on a spot produces instant effect which persists for a long time so that instillations twice a day (BID) are enough. Levocabastine is more effective than other 15 antihistamines. In contrast to previous antihistamines, levocabastine blocks vasodilatation and reduces vascular permeability increase. Levocabastine eye drops have good tolerability comparable with cromoglicic acid eye drops and placebo. Levocabas tine is successfully used in allergic conjunctivitis (pollinosis, perennial, vernal, rhinoconjunctivitis) treatment in children. Its efficacy is the same or even higher than that of cromoglycate and azelastine. 20 clinical studies (more than 1200 patients) revealed that levocabastine eye drops are effective, work quickly and have good tolerability. This drug is efficient in allergic conjunctivitis treatment and acute infectious conjunctivitis complex therapy.
References
1. Abelson M. B., Weintraub D. Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitis. Eur. J. Ophthalmol. 1994; 4 (2): 91‑101.
2. Weeke E. R. Epidemiology of hay fever and perennial allergic rhinitis. Monogr. Allergy. 1987; 21: 1‑20.
3. Freidlander M. H. Allergic conjunctivitis. In: Current ocular therapy. Ed. F. T. Frannfeder. F. H., Roy J. W. B. Randall Saunders Comp. 2000; 323.
4. Il’ina N. I. [Allergic rhinitis]. Allergicheskii rinit. [Allergy, asthma and clinical immunology]. Allergiya, astma i klinicheskaya immunologiya 1997; 4: 2024. (in Russ.).
5. Maichuk Yu. F. [Allergic diseases of eyes]. Allergicheskie zabolevaniya glaz. M.; Medicine 1983. 224 с. (in Russ.).
6. Bogacka F. Epidemiology of allergic eye disease. Pol. Merkuriuzs. Lek. 2003; 84:714‑715.
7. Remhard T., Larkin F. Cornea and external eye disease. Springer. 2006. 229 p.
8. World Health Organization. Prevention of allergic asthma. WHO Geneva. WHO / NMH / MNC / CRA / — 03.02.2003.
9. Ono S. L., Abelson M. B. Allergic conjunctivitis update on pathophysiology and prospects for future treatment. J. Allergy Chn. Immunol. 2005; 115: 118‑122.
10. Palmares J., Larkin F. Ocular Allergy. Medisa. 1997. 94 р.
11. Maichuk Yu. F. [Seasonal polynosic conjunctivitis — the most widespread form eye allergy. UGLY FACES]. Sezonnyi pollinoznyi kon’yunktivit — samaya rasprostranennaya forma glaznykh allergozov. Russian ophthalmologic Journal 2010; 1: 37‑41. (in Russ.).
12. Grigoryan A. R., Maichuk D. Yu. [Features of a course of adenoviral conjunctivitis during season 2008‑2009]. [Actual problems of ophthalmology. Proc. IV conf.. young scientists]. Aktual’nye problemy oftal’mologii. IV Vseros. nauch. konf. molodykh uchenykh. М. 2009; 255‑257. (in Russ.).
13. Maichuk D. Yu. [Blepharitis — demodecosis, allergy, infection — as to connect it. New in ophthalmology]. Blefarity — demodekoz, allergiya, infektsiya — kak eto svyazat’. Novoe v oftal’mologii. 2013; 3: 42‑47. (in Russ.).
14. Noble S., McTavish D. Levocabastin. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis. Drugs. 1995; 50. b.: 1032‑1049.
15. Maichuk Yu. F., Khaitova K. N., Grishakova M. B., Yani E. V. [Eye drops levocobastin in treatment of allergic conjunctivitis]. [V national. congress «Person and medicine»]. Glaznye kapli levokabastina v lechenii allergicheskikh kon’yunktivitov. V Ros. nats. kongress «Chelovek i lekarstvo». 1998; 127‑128. (in Russ.).
16. Maichuk Yu. F., Khaitova K. N., Yani E. V. [Levokabastin (hystimet) in treatment of allergic conjunctivitis]. Levokabastin (gistimet) v lechenii allergicheskikh kon’yunktivitov. Sb. trudov «Sovremennye problemy allergologii, klinicheskoi immunologii i immunofarmakologii». [Works «Modern Problems of Allergology, Clinical Immunology and Immunopharmacology»]. М.; 1998; 777. (in Russ.).
17. Maichuk Yu. F. [Allergic diseases of eyes]. Allergicheskie zabolevaniya glaz. Russian ophthalmologic Journal. 199; 7 (1):20‑22.
18. [Visine® the classical]. Vizin® klassicheskii. Registr lekarstvennykh sredstv [Register of medicines of Russia. Ophthalmology. RLS]. Rossii. Oftal’mologiya. RLS. М:, 2012; 75‑77. (in Russ.).
19. [Visin® pure tear]. [Register of medicines of Russia. Ophthalmology]. RLS.Vizin® chistaya sleza. Registr lekarstvennykh sredstv Rossii. Oftal’mologiya. RLS. М., 2012; 77‑79. (in Russ.).
20. Weston J. H., Udell I. J., Abelson M. B. H1‑receptors in the human ocular surface. Invest OPhthalmol Vis Sci. 1981; 20: 32.
21. Abelson M. B., Udell I. J. H2‑receptors in the human ocular surface. Arch. Ophthalmol. 1981; 99:302‑4.
22. Dechant K. L., Goa K. L. Levocabastine: a review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Drugs 1991; 41:202‑4.
23. Berdy G. J., Abelson M. B., George M. A., Smith L. M., Giovanoni R. L. Allergic conjunctivitis: a survey of new antihistamines. J. Ocular Pharmacol 1991; 7:313‑24.
24. Frostad A. B., Olsen A. K. A comparison of topical levocabastine and sodium cromoglycate eyedrops in the treatment of pollen-provoked allergic conjunctivitis. Clin Exp Allergy 1993; 23: 406‑9.
25. Moller C., Björksten B., Nillson G., Dreorg S. The precision of the conjunctival provocation test with allergen. Allergy 1984; 39: 37‑41.
26. Abelson M. B., Smith L. M. The conjunctival provocation test: a new method for the evaluation of therapeutic agents. Invest Ophthalmol Vis Sci 1988; 28 (suppl): 45 (abstr.).
27. Smith L. M., Southwick P. C., DeRosia D. R., Abelson M. B. The effects of levocabastine, a new highly potent and specific histamine H1‑peceptor antagonist, in the ocular allergen challenge model of allergic conjunctivitis. Invest Ophthalmol
28. Visual Sci 1989; 30: 502.
29. Jannsens M. M. L. Efficacy of levocabastine in conjunctival provocation studies. Doc Ophthalmol 1993; 82 (4): 341‑51.
30. Abelson M. B., Smith L. M., George M. A. A double-masked paired comparison of the effects of 0.5 % levocabastine and cromolyn sodium on the signs and symptoms of ocular allergy. Ophthalmology 1991; 30 (suppl): 11 (abstr.).
31. Zuber P., Pecoud A. Effect of levocabastine, a new H1‑antagonist in a conjunctival provocation test with allergens. J. Allergy Clin Immunol. 1988; 82: 590‑4.
32. Rimas M., Kjellman N. I. M., Blychert L. O., Bjorksten B. Topical levocabastine protects better then sodium cromoglycate and placebo in conjunctival provocation tests. Allergy 1990; 45: 18‑21.
33. StokesT.C., Feinberg G. Rapid onset of action of levocabastine eye-drops in histamineinduced conjunctivitis. Clin Exp Allergy 1993; 23 (9): 791‑8.
34. Janssens M. M. L., Vanden Bussche G. Levocabastine: an effective topical treatment for allergic rhinoconjunctivitis. Clin Exp Allergy 1991: 21:29‑36.
35. Dechant K. L., Goa K. L. Levocabastine: a review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Drugs 1991 Feb; 41: 202‑24.
36. Howarth P. H., Fell P., Selvam A. Levocabastine in allergic conjunctivitis [abstract]. Clin Exp Allergy 1994 Feb; 24: 184.
37. Bonini St., Pierdomenico R., Bonini S. Levocabastine eye drops in vernal keratoconjunctivitis [abstract]. Allergy 1993; 48 Suppl. 16:41.
38. Goes F., Blockhuys S., Janssens M. Levocabastine eye drops in the treatment of vernal conjunctivitis. Doc Ophthalmol 1994; 87 (3): 271‑81.
39. Azevedo M., Castel-Branco M. G., Ferraz Oliveira J. et al. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis. Clin Exp Allergy 1991 Nov; 21: 689‑94.
40. Davies B. H., Mulhns J. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis. Allergy 1993 Oct; 48: 519‑24.
41. The Livostin Study Group. A comparison of topical levocabastine and oral terfenadine in the treatment of allergic rhinoconjunctivitis. Allergy 1993 (still in press).
42. Bende M., Pipkorn U. Topical levocabastine, a selective H1‑antagonist in seasonal allergic conjunctivitis. Allergy 1987; 42: 512‑5.
43. The Livostin study Group// A comparison of topical levocabastine and oral terfenadine. Allergy 1999 May; 42: 530‑534.
44. Tiszler C. E., Nowak W., Gluza J. A comparison of levocabastine and sodium cromoglycate in children with allergic conjunctivitis due to house dust mite [abstract]. Allergy Clin Immunol News 1994; Suppl 2:16.
45. Wuthrich B., Gerber M. Levocabastine eye drops are effective and well tolerated for the treatment of allergic conjunctivitis in children. Mediators Inflamm. 1995; 4 Suppl. 1: 516‑20.
46. Graue-Wiechers E., Garcia-Valenzuela E. Double blind study of topical levocabastine versus topical placebo in the management of vernal conjunctivitis [translation]. Investigation Medica International: 1994; 21: 35‑42.
47. Moller C., Blychert L-O Levocabastine eye drops in comparison with cromoglycate in the treatment on conjunctivitis in children with brich pollinosis. Pediatr Allergy Immunol. 1990; 1: 87‑89.
48. Njaa F., Baekken t., Bjaamer D. et al. Levocabastine compared with sodium cromoglycate eyedrops in children with both birch and grass pollen allergy. Pediatr Allergy Immunol: 1992; 3: 39‑42.
49. Clinical Research Report. R50547 / 30. [Evens P., Bocquie BG, Rombaut N., Neetens A. (investigators: no author provided)] Levocabastine versus placebo and cromoglycate in atopic conjunctivitis. A double-blind placebo controlled study. Janssen Pharmaceutica. 1986.
50. Sawa M., Masuda K., Kitano S. et al. Clinical evaluation of R50547 ophthalmic suspension in allergic conjunctivitis and vernal conjunctivitis — open study in children [translation]. Atarashii Ganka (Journal of the eye); 1994: 11 (12):1893‑1902.
51. Bonini S., Pierdomenico R., Bonini S. Levocabastine eye drops in vernal keratoconjunctivitis. Annual Meeting of the European Academy of Allergology and Clinical Immunology, Rotterdam, The Netherlands. September 12‑15, 1993. Allergy;1993; 48 (16, Suppl): 41.
52. Sabbah A., Marzetto M. Azelastine eye drops in the treatment of seasonal allergic conjunctivitis or rhinoconjunctivitis in young children. Curr Med Res OPin; 1998; 14 (3): 161‑176.
Review
For citations:
Maychuk D.Yu. Modern opportunities of therapeutic treatment of allergic conjunctivitis. A review. Ophthalmology in Russia. 2014;11(2):19-26. https://doi.org/10.18008/1816-5095-2014-2-19-26
Views:
2039
Email this article 